Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high
HYDERABAD: Pharma major Aurobindo Pharma on Wednesday informed the bourses that the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa injection), a novel long-acting Granulocyte colony-stimulating factor …